Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-006 · Safety

HG-11: Testosterone-therapy cautions to review

Testosterone-therapy cautions to review. Evaluates testosterone therapy under consideration.

Active rulePriority 2Testosterone engine v1.0.0

Condition

  • testosterone therapy under consideration
  • any of: prostate cancer, breast cancer, palpable prostate nodule or induration, PSA > 4 ng/mL, hematocrit > 50%, untreated severe sleep apnea, severe lower urinary tract symptoms, unstable heart failure, myocardial infarction or stroke in the last 6 months, thrombophilia

What it reports

  • Endocrine Society cautions or contraindications to testosterone therapy are present

Recommended next steps (for physician review)

  • Resolve or evaluate each flag before any decision on therapy

Never outputs

  • a recommendation to start testosterone therapy

Diagnostic boundary

  • A screen of cautions. It is never an indication.

Evidence

  • EV-ES-TRT-2018Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.Supports: Diagnose with symptoms plus unequivocally low testosterone on two morning fasting samples Contraindications and cautions to therapy; monitoring of hematocrit and PSA Evaluation of the type of hypogonadism with LH and FSH
  • EV-TRAVERSE-2023Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107-117.Supports: Cardiovascular safety data in hypogonadal men at increased cardiovascular risk, with higher rates of atrial fibrillation, pulmonary embolism and acute kidney injury

Cases where this rule fires

Open a case to see this rule fire with real inputs, then change the values until it stops.

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod